netFormulary Oxfordshire Clinical Commissioning Group NHS
Formulary  
 Search
 Formulary Chapter 13: Skin - Full Chapter
13.08.01  Expand sub section  Sunscreen preparations
 note 
  • Sunscreen preparations are regarded as drugs when prescribed for skin protection against ultraviolet radiation in abnormal cutaneous photosensitivity resulting from genetic disorders or photodermatoses, including vitiligo, those resulting from radiotherapy and chronic or recurrent herpes simplex labialis.
  • Prescriptions used in this way should be marked "ACBS" (Advisory Committee on Borderline Substances).
13.08.01  Expand sub section  Photodamage
Cytotoxic Drug Fluorouracil cream (Efudix®)
View adult BNF View SPC online View childrens BNF
First Choice
Green

First-line for multiple lesions in line with Oxfordshire Solar Keratosis Primary Care Treatment Pathway.

APCO November 2015.

 
Imiquimod 5% cream  (Aldara®)
(Actinic Keratosis)
View adult BNF View SPC online View childrens BNF
Third Choice
Green

Third-line for multiple lesions in line with Oxfordshire Solar Keratosis Primary Care Treatment Pathway.

APCO November 2015.

 
   
Fluorouracil and Salicylic acid (Actikerall® cutaneous solution)
(Actinic Keratosis)
View adult BNF View SPC online View childrens BNF
Formulary
Green

For single lesions or hyperkeratotic lesion in line with Oxfordshire Solar Keratosis Primary Care Treatment Pathway.

APCO November 2015.

 
   
Methyl-5-Aminolevulinate (Metvix®)
View adult BNF View SPC online View childrens BNF
Formulary
Red

For prescribing by dermatologists only in secondary care. For photochemotherapy combining long-wave ultraviolet A radiation with a psoralen (PUVA) treatment only. 

 
   
Actinica lotion
View adult BNF View SPC online View childrens BNF
Formulary
Red

For prescribing by dermatologists only in secondary care. For daylight photodynamic therapy (PDT). 

APCO March 2018.

 
   
P20 cream (SPF 50)
View adult BNF View SPC online View childrens BNF
Formulary
Red

For prescribing by dermatologists only in secondary care. For daylight photodynamic therapy (PDT). 

 
   
 ....
 Non Formulary Items
Diclofenac Sodium 3% gel  (Solaraze®)

View adult BNF View SPC online View childrens BNF
Non Formulary

Not recommended due to lack of evidence.

 
Imiquimod 3.75% cream  (Zyclara®)
(Actinic Keratosis)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not recommended due to insufficient evidence of advantage over other treatment options or cost efficacy.

APCO May 2007.

 
Ingenol mebutate  (Picato®)

View adult BNF View SPC online View childrens BNF
Non Formulary

Do not prescribe as the marketing authorisation is currently suspended as a precautionary measure due to growing concerns on the possible risk of skin malignancy, while EMA continues to investigate.

 

 

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Red: Medicines which should only be prescribed in secondary care by a specialist.  

Amber Continuation

Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.   

Amber Shared Care Protocol

Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).   

Green

Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.   

Brown

Brown: Medicines which should only be prescribed in restricted circumstances.  

Black

Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.  

OCCG Green

not used  

netFormulary